TCTR20180614002已完成4 期
Comparative efficacy of daily inhaled fluticasone propionate and episodic inhaled combined salmeterol/fluticasone propionate in children with recurrent wheezing
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Years 至 15 Years（—）
- 性别
- All
入选标准
- •1. History of recurrent wheezing at least 3 times/year and at least 2 of 5 symptom patterns tending to be asthma
- •- Cough or wheeze more than 10 days during upper respiratory tract infection
- •- Night worsening symptoms, cough or wheeze triggered by exercise and/or laughing and/or crying
- •- History of atopy such as atopic dermatitis, allergic rhinitis
- •- First degree relatives with asthma
- •- Diagnosed asthma by spirometry
排除标准
- •1. Children who have history of using medications for controlling their recurrent wheezing symptoms such as Inhaled corticosteroids and/or leukotriene receptor antagonists before recruitment
研究者
相似试验
已完成
不适用
Daily versus intermittent inhaled fluticasone in toddlers with recurrent wheezingInfants and toddlers with recurrent wheezing (infantile asthma)JPRN-UMIN000016736Jikei University500
进行中（未招募）
不适用
A 6-month study to assess the safety and benefit of inhaled fluticasone propionate/salmeterol combination compared with inhaled fluticasone propionate in the treatment of adolescents (12 years and over) and adults with asthma.AsthmaMedDRA version: 17.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-001644-29-CZGlaxoSmithKline Research & Development Limited11,664
进行中（未招募）
1 期
A Comparison of Fluticasone Furoate Nasal Spray versus Oral Fexofenadine in the Treatment of Seasonal allergiesEUCTR2015-004885-27-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd936
进行中（未招募）
不适用
A study of the Effects of Inhaled Fliticasone Furotate/GW642444 versus Placebo on HPA Axis of Adolescent and Adult Asthmatics.Adolescent (12-17 years) and Adult AsthmathicsMedDRA version: 12.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-017669-44-PLGlaxoSmithKline185
已完成
不适用
ebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy studyACTRN12615000096550Safa Baris100